| SC 13G/A | 2022-02-14 | Consonance Capital Management LP | GenMark Diagnostics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-05-10 | WASATCH ADVISORS INC | GenMark Diagnostics, Inc. | - | - | EDGAR |
| SC 13G/A | 2021-04-12 | FMR LLC | GenMark Diagnostics, Inc. | 79,997 | 0.1% | EDGAR |
| SC 13D | 2021-03-26 | Magnetar Financial LLC | GenMark Diagnostics, Inc. | 4,221,792 | 5.7% | EDGAR |
| SC 13G | 2021-02-17 | Consonance Capital Management LP | GenMark Diagnostics, Inc. | 4,480,163 | 6.2% | EDGAR |
| SC 13G | 2021-02-16 | Consonance Capital Management LP | GenMark Diagnostics, Inc. | 4,480,163 | 6.2% | EDGAR |
| SC 13G | 2021-02-16 | Redmile Group, LLC | GenMark Diagnostics, Inc. | 4,537,400 | 6.3% | EDGAR |
| SC 13G/A | 2021-02-12 | CADIAN CAPITAL MANAGEMENT, LP | GenMark Diagnostics, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | GenMark Diagnostics, Inc. | 4,497,904 | 6.3% | EDGAR |
| SC 13G | 2021-02-09 | WASATCH ADVISORS INC | GenMark Diagnostics, Inc. | - | - | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | GenMark Diagnostics, Inc. | 10,758,659 | 15.0% | EDGAR |
| SC 13G/A | 2021-01-29 | BlackRock Inc. | GenMark Diagnostics, Inc. | 5,623,577 | 7.8% | EDGAR |
| SC 13D/A | 2020-05-18 | Casdin Capital, LLC | GenMark Diagnostics, Inc. | 2,555,000 | 4.1% | EDGAR |
| SC 13G/A | 2020-05-07 | MORGAN STANLEY | GenMark Diagnostics, Inc. | 7,412 | 0.0% | EDGAR |
| SC 13G/A | 2020-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | GenMark Diagnostics, Inc. | 2,113,579 | 3.6% | EDGAR |
| SC 13G/A | 2020-02-13 | MORGAN STANLEY | GenMark Diagnostics, Inc. | 5,153,330 | 8.9% | EDGAR |
| SC 13G/A | 2020-02-13 | CADIAN CAPITAL MANAGEMENT, LP | GenMark Diagnostics, Inc. | 5,517,767 | 9.5% | EDGAR |
| SC 13G | 2020-02-11 | VANGUARD GROUP INC | GenMark Diagnostics, Inc. | 3,163,795 | 5.4% | EDGAR |
| SC 13D/A | 2020-02-07 | Casdin Capital, LLC | GenMark Diagnostics, Inc. | 3,365,000 | 5.8% | EDGAR |
| SC 13G/A | 2020-02-07 | FMR LLC | GenMark Diagnostics, Inc. | 8,709,057 | 15.0% | EDGAR |